Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 2,505.00
-140.00 (-5.29%)
At close: Oct 23, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 57.93 billion as of October 23, 2026. It is the 31,058th most valuable company in the world and the 1,683rd biggest in South Korea. Its market cap has decreased by 16.29% in one year.
Market Cap
57.93B
Enterprise Value
50.13B
Revenue
27.38B
Global Rank
Country Rank
#1,683 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 22, 2018, Cytogen's market cap has decreased from 87.89B to 57.93B, a decrease of -34.08%. That is a compound annual growth rate of -5.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 57.93B | -72.07% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 201.78B |
| 3billion | 168.02B |
| GC Medical Science | 97.05B |
| Inventera | 71.97B |
| Protia | 71.48B |
| HLB Panagene | 66.33B |
| GENINUS | 62.20B |
| Seoulin Bioscience | 34.86B |